Hudson Therapeutics, US Subsidiary of Shaperon has ingeniously crafted a platform that seamless integrates anti-inflammatory and immunology drugs to cater to the global market's needs.
Company Details
- Employees
- 3
- Founded
- 2023
- Address
- 600 Park Office Dr,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://HudsonTherapeutics.com
- Keywords
- biotechnology, anti-inflammatory, immunology, atopic dermatitis, inflammasome inhibitor, Alzheimer, Orphan Disease, Nanobody.
- HQ
- Durham, North Carolina
Hudson Therapeutics, Us Subsidiary Of Shaperon Questions
Hudson Therapeutics, Us Subsidiary Of Shaperon's website is http://HudsonTherapeutics.com
Hudson Therapeutics, Us Subsidiary Of Shaperon's LinkedIn profile is https://www.linkedin.com/company/shaperonusa
Hudson Therapeutics, Us Subsidiary Of Shaperon has
3 employees.
View email and phone details for 3
employees at Hudson Therapeutics, Us Subsidiary Of Shaperon.
Hudson Therapeutics, Us Subsidiary Of Shaperon's industry is
Biotechnology Research
Hudson Therapeutics, Us Subsidiary Of Shaperon's top competitors are
Vibrant Gastro®,
Scl Lifesciences Limited,
Syenex,
Bdm Collective,
Sanwa Kagaku Kenkyusho Co., Ltd.,
Ecommerce Marketing Consultant,
Virogin Biotech,
Scatr,
Sever Pharma Solutions,
Shaperon.
Hudson Therapeutics, Us Subsidiary Of Shaperon's categories are Biotechnology Research
Hudson Therapeutics, Us Subsidiary Of Shaperon's founding year is 2023
